Fueling Open‐Source Drug Discovery: 177 Small‐Molecule Leads against Tuberculosis

Abstract

With the aim of fuelling open‐source, translational, early‐stage drug discovery activities, the results of the recently completed antimycobacterial phenotypic screening campaign against Mycobacterium bovis BCG with hit confirmation in M. tuberculosis H37Rv were made publicly accessible. A set of 177 potent non‐cytotoxic H37Rv hits was identified and will be made available to maximize the potential impact of the compounds toward a chemical genetics/proteomics exercise, while at the same time providing a plethora of potential starting points for new synthetic lead‐generation activities. Two additional drug‐discovery‐relevant datasets are included: a) a drug‐like property analysis reflecting the latest lead‐like guidelines and b) an early lead‐generation package of the most promising hits within the clusters identified.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 27

1. 1.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

2. 2.

   Berry M, Kon OM. Eur. Respir. Rev. 2009;18:195-197.

   Not in our library10.1183/09059180.00005209

3. 3.

   Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D, Boulabhal F, Paramasivan CN, Kam KM, Mitarai S, Nunn P, Raviglione M. Lancet. 2009;373:1861-1873.

   Not in our library10.1016/s0140-6736(09)60331-7

4. 4.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

5. 5.

   Goldman R, Gabriel RP. Innovation Happens Elsewhere. 2005.

   Not in our library

6. 6.

   Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DVS, Kumar V, Hasan S, Brown JR, Peishoff CE, Cardon LR, Garcia-Bustos JF. Nature. 2010;465:305-310.

   Not in our library10.1038/nature09107

7. 7.

   Brown D. Drug Discovery Today. 2007;12:1007-1012.

   Not in our library10.1016/j.drudis.2007.10.017

8. 8.

   Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. Nat. Rev. Drug Discovery. 2007;6:29-40.

   Not in our library10.1038/nrd2201

9. 9.

   Rullas J, García JI, Beltrán M, Cardona P-J, Cáceres N, García-Bustos JF, Angulo-Barturen I. Antimicrob. Agents Chemother. 2010;54:2262-2264.

   Not in our library10.1128/aac.01423-09

10. 10.

    Ordway DJ, Orme IM. Curr. Protoc. Immunol. 2011.

    Not in our library10.1002/0471142735.im1905s94

11. 11.

    Goldman RC, Laughon BE. Tuberculosis. 2009;89:331-333.

    Not in our library10.1016/j.tube.2009.07.007

12. 12.

    Garnier T, Eiglmeier K, Camus JC, Medina N, Mansoor H, Pryor M, Duthoy S, Grondin S, Lacroix C, Monsempe C, Simon S, Harris B, Atkin R, Doggett J, Mayes R, Keating L, Wheeler PR, Parkhill J, Barrell BG, Cole ST, Gordon SV, Hewinson RG. Proc. Natl. Acad. Sci. USA. 2003;100:7877-7882.

    Not in our library10.1073/pnas.1130426100

13. 13.

    Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Adv. Drug Delivery Rev. 2001;46:3-26.

    Not in our library10.1016/s0169-409x(00)00129-0

14. 14.

    Butina D. J. Chem. Inf. Comput. Sci. 1999;39:747-750.

    Not in our library

15. 15.

    Koul A, Arnoult E, Lounis N, Guillemont J, Andries K. Nature. 2011;469:483-490.

    Not in our library10.1038/nature09657

16. 16.

    Kaneko T, Cooper C, Mdluli K. Future Med. Chem. 2011;3:1373-1400.

    Not in our library10.4155/fmc.11.115

17. 17.

    Mak PA, Rao SPS, Tan MP, Lin X, Chyba J, Tay J, Ng SH, Tan BH, Cherian J, Duraiswamy J, Bifani P, Lim V, Lee BH, Ma NL, Beer D, Thayalan P, Kuhen K, Chatterjee A, Supek F, Glynne R, Zheng J, Boshoff HI, Barry CE, Dick T, Pethe K, Camacho LR. ACS Chem. Biol. 2012;7:1190-1197.

    Not in our library10.1021/cb2004884

18. 18.

    Young RJ. Bioorg. Med. Chem. Lett. 2011;21:6228-6235.

    Not in our library10.1016/j.bmcl.2011.08.119

19. 19.

    Hill AP, Young RJ. Drug Discovery Today. 2010;15:648-655.

    Not in our library10.1016/j.drudis.2010.05.016

20. 20.

    Young RJ, Green DVS, Luscombe CN, Hill AP. Drug Discovery Today. 2011;16:822-830.

    Not in our library10.1016/j.drudis.2011.06.001

21. 21.

    Kajbaf M, Longhi R, Montanari D, Vinco F, Rigo M, Fontana S, Read KD. Drug Metab. Lett. 2011;5:30-39.

    Not in our library10.2174/187231211794455262

22. 22.

    Ananthan S, Faaleolea ER, Goldman RC, Hobrath JV, Kwong CD, Laughon BE, Maddry JA, Mehta A, Rasmussen L, Reynolds RC, Secrist JA, Shindo N, Show DN, Sosa MI, Suling WJ, White EL. Tuberculosis. 2009;89:334-353.

    Not in our library10.1016/j.tube.2009.05.008

23. 23.

    Maddry JA, Ananthan S, Goldman RC, Hobrath JV, Kwong CD, Maddox C, Rasmussen L, Reynolds RC, Secrist JA, Sosa MI, White EL, Zhang W. Tuberculosis. 2009;89:354-363.

    Not in our library10.1016/j.tube.2009.07.006

24. 24.

    Moraski GC, Markley LD, Hipskind PA, Boshoff H, Cho S, Franzblau SG, Miller MJ. ACS Med. Chem. Lett. 2011;2:466-470.

    Not in our library10.1021/ml200036r

25. 25.

    Grzegorzewicz AE, Pham H, Gundi VAKB, Scherman MS, North EJ, Hess T, Jones V, Gruppo V, Born SEM, Korduláková J, Chavadi SS, Morisseau C, Lenaerts AJ, Lee RE, McNeil MR, Jackson M. Nat. Chem. Biol. 2012;8:334-341.

    Not in our library10.1038/nchembio.794

26. 26.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

27. 27.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

Cited by papers we hold 7

• Development of a novel secondary phenotypic screen to identify hits within the mycobacterial protein synthesis pipeline · 2020
  Not checked
• Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery · 2017
  No notice
• Lansoprazole is an antituberculous prodrug targeting cytochrome bc1 · 2015
  No notice
• A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis · 2013
  No notice
• Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3 · 2013
  No notice
• The ChEMBL bioactivity database: an update · 2013
  No notice
• Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.